COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03455322
Recruitment Status : Unknown
Verified January 2018 by Eman Desoki, National Hepatology & Tropical Medicine Research Institute.
Recruitment status was:  Recruiting
First Posted : March 6, 2018
Last Update Posted : March 8, 2018
Information provided by (Responsible Party):
Eman Desoki, National Hepatology & Tropical Medicine Research Institute

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 15, 2018